CLINICAL_TRIALS
trial_result
· 2018-07-26
Clinical Trial Update: The Treatment of Depression With Botulinum Type A Toxin [Phase 2]
Summary
Phase 2 trial evaluating botulinum toxin type A for treatment of depression completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Seton Healthcare Family | Conditions: Depression | Phase 2 | Status: COMPLETED | Results posted: 2018-07-26